Events2Join
Risk factors for POD24 in patients with previously untreated follicular ...

Risk factors for POD24 in patients with previously untreated follicular ...

Risk factors for POD24 in patients with previously untreated follicular ...

Progression of disease within 24 months (POD24) is strongly associated with a poor outcome in patients with follicular lymphoma (FL).

Risk factors for POD24 in patients with previously untreated follicular ...

Correction to: Risk factors for POD24 in patients with previously untreated follicular lymphoma: a systematic review and meta‑analysis ... Ann Hematol. 2022 Dec; ...

Risk factors for POD24 in patients with previously untreated follicular ...

Meta-analyses were performed in 31 studies with 11 factors. Results showed that elevated sIL-2R, β2m and LDH, total metabolic tumour volume > ...

Risk factors for POD24 in patients with previously untreated follicular ...

Abstract. Progression of disease within 24 months (POD24) is strongly associated with a poor outcome in patients with follicular lymphoma (FL).

Risk factors for POD24 in patients with previously untreated follicular ...

This is the first study that comprehensively analysed the prognostic factors associated with POD24 in FL patients and confirmed the significance value of ...

POD24 Predicts Poor Prognosis in Follicular Lymphoma

Disease progression within 24 months of frontline chemoimmunotherapy (POD24) was highly predictive of poor prognosis in patients with follicular lymphoma (FL).

Risk factors for POD24 in patients with previously untreated follicular ...

Correction to: Risk factors for POD24 in patients with previously untreated follicular lymphoma: a systematic review and meta‑analysis.

Validation of POD24 as a robust early clinical end point of poor ...

Risk factors for POD24 included male sex, poor performance status, high-risk FLIPI score, and elevated β2-microglobulin. · We validated POD24 as ...

Risk factors for POD24 in patients with previously untreated follicular ...

High serum vascular endothelial growth factor (VEGF) level is an adverse prognostic factor in high risk diffuse large B-cell lymphoma (DLBCL) patients treated ...

Risk factors for POD24 in patients with previously untreated follicular ...

... Risk factors for POD24 in patients with previously untreated follicular lymphoma: a systematic review and meta‑analysis | Find, read and ...

Analyzing the risk factors for disease progression within 2 years and ...

Some patients exhibit shorter survival and experience disease progression within 24 months of diagnosis/treatment (POD24); the optimal treatment ...

Lymphoma | Correction to: Risk factors for POD24 in patients with ...

Correction to: Risk factors for POD24 in patients with previously untreated follicular lymphoma: a systematic review and meta‑analysis.

Association of early disease progression and very poor survival in ...

Early disease progression in patients with follicular lymphoma was associated with poor prognosis, with mortality risk higher after earlier progression.

Survival by First-line Treatment Type and Timing of Progression

In follicular lymphoma (FL), progression of disease ≤24 months (POD24) has emerged as an important prognostic marker for overall survival (OS).

Impact of early relapse within 24 months after first-line systemic ...

POD24 was also evaluated as a potential prognostic factor in MZL by Luminari et al. [8]. In that study, 76% of patients received ...

Predicting early progression in follicular lymphoma - Liu

POD24 occurred in 15% and 18% of the previously mentioned GLSG and BC Cancer cohorts, respectively, and 70–78% of POD24 cases were classified as high-risk by ...

Minimal Residual Disease Status Predicts Outcome in Patients With ...

... previously untreated patients with symptomatic follicular lymphoma (FL). ... earlier investigational time points for optimized risk ...

Progression of disease within 2 years (POD24) is a clinically ...

Risk factors for POD24 in patients with previously untreated follicular lymphoma: a systematic review and meta-analysis. Gao F, Zhang T, Liu H, Li W, Liu X ...

Early Relapse in First-Line Follicular Lymphoma - HAL

G-chemotherapy appears to reduce the risk of POD24 relative to R-chemotherapy in patients with previously untreated FL, but the impact on ...

Survival Outcomes of Patients with Follicular Lymphoma after ...

At the median follow-up of 104 months (95% CI: 90-118 months), POD24 patients experienced significantly worse OS than patients without POD24, ...